Iatrogenic Right Bundle Branch Block Correction by Left Bundle Branch Area Pacing
Hironobu Sumiyoshi1, Akira Mizukami2, Takumi Arashiro3
1Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan; Department of Cardiology, Kameda Medical Center, Kamogawa, Chiba, Japan.
Background:
Correction of right bundle branch block (RBBB) by left bundle branch area pacing (LBBAP) has traditionally been attributed to capture within a longitudinally dissociated His bundle. Based on this theory, conduction block in the distal right bundle would not be expected to resolve.
Case Summary:
We describe a 90-year-old man with cardiac amyloidosis who underwent pacemaker implantation. During the procedure, advancement of the delivery catheter toward the right ventricular septum induced iatrogenic complete RBBB. Remarkably, pacing from this site corrected the block. The lead was then advanced >2 cm intraseptally, achieving successful LBBAP. Postoperatively, intrinsic conduction remained as RBBB, but unipolar pacing consistently corrected it.
Discussion:
Correction of an iatrogenic RBBB by LBBAP suggests the involvement of a septal intramyocardial conduction network as a potential mechanism.
Take-Home Message:
RBBB due to a lesion distal to the His bundle may be correctable with LBBAP.
More Related Videos
10:17Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
06:57Ablation of Ischemic Ventricular Tachycardia Using a Multipolar Catheter and 3-dimensional Mapping System for High-density Electro-anatomical Reconstruction
Published on: January 31, 2019
Related Concept Videos
Dysrhythmias VI: Management of Dysrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiac Catheterization II: Right Heart Catheterization
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
